AdaptHealth (AHCO) Non-Current Deffered Revenue (2018 - 2019)
AdaptHealth's quarterly Non-Current Deffered Revenue came in at $7.9 million in Q3 2019, little changed year-on-year from $7.9 million in Q3 2018, and little changed quarter-over-quarter from $7.9 million in Q2 2019.
AdaptHealth has reported Non-Current Deffered Revenue for 2 years, with the latest figure at $7.9 million in Q3 2019.
- For the quarter ending Q3 2019, Non-Current Deffered Revenue changed 0.0% year-over-year to $7.9 million; the trailing twelve-month figure through Sep 2019 stood at $7.9 million (changed 0.0% YoY), and the FY2018 full-year result was $7.9 million, changed N/A from the prior year.
- Non-Current Deffered Revenue for Q3 2019 stood at $7.9 million, roughly flat from $7.9 million in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $7.9 million in Q1 2018, with the low at $7.9 million in Q1 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 512.79 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | AdaptHealth | 1.35 Bn | 1.31 Bn | 111.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 7.88 Mn |
| Jun 30, 2019 | 7.88 Mn |
| Mar 31, 2019 | 7.88 Mn |
| Dec 31, 2018 | 7.88 Mn |
| Sep 30, 2018 | 7.88 Mn |
| Jun 30, 2018 | 7.88 Mn |
| Mar 31, 2018 | 7.88 Mn |